Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Animal evaluation of technetium-99m triamide mercaptide complexes as potential renal imaging agents

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6276235

Technetium-99m mercaptoacetylglycylglycylglycine (MAG3), a (/sup 99m/Tc)triamide mercaptide (N3S) compound has been synthesized in an attempt to obviate the stereochemistry problems associated with the diamide dimercaptide (N2S2) ligands. Because initial studies have been promising, the terminal glycine on the MAG3 compound has been varied to create a new series of N3S compounds. Twelve new N3S complexes were initially screened in mice and the more promising complexes, /sup 99m/Tc mercaptoacetylgylcylglycyl-glycine ((/sup 99m/Tc)MAG3), /sup 99m/Tc mercaptoacetylgylcylglycyl-L-alanine ((/sup 99m/Tc)MAG2-Ala), and both complexes of /sup 99m/Tc mercaptoeacetylglycylglycyl-L-asparagine ((/sup 99m/Tc)MAG2-Asn) and /sup 99m/Tc mercaptoacetylglycylglycyl-L-glutamine ((/sup 99m/Tc)MAG2-Gln), were further evaluated in rats utilizing constant infusion blood clearances, extraction efficiencies and protein binding assays. The renal excretion of all these complexes compared favorably with simultaneously administered (/sup 131/I)OIH and (/sup 125/I)iothalamate. The triamide mercaptide complexes represent a new ligand class for /sup 99m/Tc, which may provide a variety of complexes for the evaluation of renal tubular function.

Research Organization:
Univ. of Utah, Salt Lake City
OSTI ID:
6276235
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 28:7; ISSN JNMEA
Country of Publication:
United States
Language:
English